These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7349145)
61. [Echocardiographic findings in subjects with beta-thalassemia major]. Malizia R; Agnello D; Lo Iacono G; Raspone C; Glorioso R Pediatria (Napoli); 1981; 89(2):235-44. PubMed ID: 6458789 [No Abstract] [Full Text] [Related]
62. Strong Man with a Weak Heart: The Ill Effects of Performance-Enhancing Drug Use. Ge Y; Liu S; Singh SM Am J Med; 2017 Jan; 130(1):e5-e7. PubMed ID: 27427320 [No Abstract] [Full Text] [Related]
63. Controversial HSC clinical trials report made public. Hospital for Sick Children. Birmingham K Nat Med; 1999 Jan; 5(1):7. PubMed ID: 9883822 [No Abstract] [Full Text] [Related]
64. A postmodern moral tale: the ethics of research relationships. Somerville MA Nat Rev Drug Discov; 2002 Apr; 1(4):316-20. PubMed ID: 12120283 [TBL] [Abstract][Full Text] [Related]
65. CJEC 2004/2, case T-326/99, Olivieri/Commisssion. Bulterman M Eur J Health Law; 2004 Mar; 11(1):109-10. PubMed ID: 15285201 [No Abstract] [Full Text] [Related]
68. Hearing loss attributed to desferrioxamine in patients with beta-thalassaemia major. Schindléry C Med J Aust; 1988 Jun; 148(12):662-3. PubMed ID: 3380052 [No Abstract] [Full Text] [Related]
70. Prophylaxis of systemic yersinosis in thalassaemia major. Scharnetzky M; König R; Lakomek M; Tillmann W; Schröter W Lancet; 1984 Apr; 1(8380):791. PubMed ID: 6143103 [No Abstract] [Full Text] [Related]
71. Biological and toxic properties of deferoxamine. Freedman MH; Bentur Y; Koren G Prog Clin Biol Res; 1989; 309():115-24. PubMed ID: 2675081 [No Abstract] [Full Text] [Related]
72. Acute changes in renal function associated with deferoxamine therapy. Li Volti S; Di Gregorio F; Schilirò G Am J Dis Child; 1990 Oct; 144(10):1069-70. PubMed ID: 2264886 [No Abstract] [Full Text] [Related]
73. [Measurement of siderinuria in thalassemia major]. Camerini G; Voghenzi A; Kalapurackal M; Menghi G Boll Soc Ital Biol Sper; 1986 Feb; 62(2):181-4. PubMed ID: 3718732 [No Abstract] [Full Text] [Related]
75. Immune status in thalassemia major. Ballart IJ; Estevez ME; Muchinik G; Sen L Haematologica; 1988; 73(2):153. PubMed ID: 3137131 [No Abstract] [Full Text] [Related]
76. [Biohumoral data and heart function in beta-thalassemia]. Monteverde R; Lattere M; De Langlade E; Romano L; Ferrando A Minerva Pediatr; 1982 May; 34(9):379-86. PubMed ID: 7121434 [No Abstract] [Full Text] [Related]
77. [Myocardiopathy induced by imipramine]. Araújo JA; de Freitas FP Arq Bras Cardiol; 1984 Mar; 42(3):209-12. PubMed ID: 6477193 [No Abstract] [Full Text] [Related]